Brigham Hyde

Brigham Hyde is an accomplished professional with extensive experience in the healthcare and technology sectors. Currently serving as a Venture Partner at Audere Capital LLC and the Chief Executive Officer at Atropos Health, Brigham has also held significant roles as President and Special Advisor at EVERSANA, and as an Official Member of the Forbes Technology Council. Between their academic contributions, Brigham has served as an Adjunct Professor of Pharmacology and Experimental Therapeutics at Tufts University and as a Research Affiliate at the Massachusetts Institute of Technology (MIT). Brigham's entrepreneurial journey includes co-founding companies such as Concerto HealthAI and Precision Health AI, and Brigham has held leadership positions in analytics and data at Decision Resources and SymphonyAI. Brigham holds a Ph.D. in Pharmacology and Experimental Therapeutics from Tufts University School of Medicine and a Bachelor's degree in Chemistry from Northeastern University.